GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma.

Schmitz KJ, Lang H, Frey UH, Sotiropoulos GC, Wohlschlaeger J, Reis H, Takeda A, Siffert W, Schmid KW, Baba HA

Open source

DOI
10.1593/neo.06796
Published
2007 Feb
Container
Neoplasia (New York, N.Y.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1593/neo.06796,
  title = {GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma.},
  author = {Schmitz KJ and Lang H and Frey UH and Sotiropoulos GC and Wohlschlaeger J and Reis H and Takeda A and Siffert W and Schmid KW and Baba HA},
  year = {2007},
  journal = {Neoplasia (New York, N.Y.)},
  doi = {10.1593/neo.06796},
  url = {https://doi.org/10.1593/neo.06796}
}

RIS

TY  - JOUR
TI  - GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma.
AU  - Schmitz KJ
AU  - Lang H
AU  - Frey UH
AU  - Sotiropoulos GC
AU  - Wohlschlaeger J
AU  - Reis H
AU  - Takeda A
AU  - Siffert W
AU  - Schmid KW
AU  - Baba HA
PY  - 2007
JO  - Neoplasia (New York, N.Y.)
DO  - 10.1593/neo.06796
UR  - https://doi.org/10.1593/neo.06796
ER  - 

APA

KJ, S., H, L., UH, F., GC, S., J, W., H, R., A, T., W, S., KW, S., & HA, B. (2007). GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma.. Neoplasia (New York, N.Y.). https://doi.org/10.1593/neo.06796

Source records